Archana Bangalore
Family Medicine · Clovis
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Archana Bangalore’s office at (559) 203-6600 to ask if they take your plan before you enroll.
California Medical Board record
Licence A157666 · Current
Licensed to practise in California · since 2018 · expires 2028-08-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Medicaid work
$668,438 in 2024
Medicaid paid $668,438 for 7,924 billed services this clinician did in 2024, up to 253 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,777 | $521,482 |
| Short return visit (20+ min) | 3,345 | $93,340 |
| Return visit (30+ min) | 1,297 | $51,043 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 215 | $1,435 |
| New patient visit (30+ min) | 30 | $624 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 43 | $345 |
| HEMOGLOBIN | 151 | $138 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 13 | $31 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 41 | $0 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 12 | $0 |
| 2024 | 7,924 | 10 | 253 | $668,438 |
| 2023 | 8,021 | 11 | 246 | $543,976 |
| 2022 | 7,512 | 12 | 279 | $504,139 |
| 2021 | 8,028 | 10 | 348 | $628,805 |
| 2020 | 6,964 | 15 | 301 | $531,695 |
| 2019 | 1,981 | 12 | 208 | $131,586 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,717 | $490,017 |
| Short return visit (20+ min) | 3,333 | $32,531 |
| Return visit (30+ min) | 1,200 | $17,643 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 128 | $1,746 |
| New patient visit (30+ min) | 31 | $752 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 258 | $554 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 12 | $430 |
| HEMOGLOBIN | 233 | $219 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Influenza, A or B, each | 25 | $63 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 69 | $20 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 15 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 2,628 | $461,566 |
| Short return visit (20+ min) | 3,512 | $28,644 |
| Return visit (30+ min) | 776 | $9,541 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B | 60 | $2,493 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 90 | $1,107 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 234 | $434 |
| HEMOGLOBIN | 125 | $158 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 21 | $108 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 18 | $85 |
| URINE PREGNANCY TEST | 15 | $3 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 20 | $0 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 13 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 3,632 | $627,122 |
| Short return visit (20+ min) | 3,047 | $1,320 |
| Return visit (30+ min) | 683 | $303 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 241 | $27 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 35 | $25 |
| HEMOGLOBIN | 169 | $9 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 12 | $0 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 28 | $0 |
| Bilateral quantitative screening test of visual acuity | 14 | $0 |
| New patient visit (30+ min) | 167 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 3,230 | $531,031 |
| Short return visit (20+ min) | 2,681 | $602 |
| New patient visit (30+ min) | 302 | $63 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 76 | $0 |
| URINE PREGNANCY TEST | 13 | $0 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 13 | $0 |
| HEMOGLOBIN | 58 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 22 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 53 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 120 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 24 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 34 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 833 | $131,474 |
| New patient visit (30+ min) | 114 | $63 |
| Short return visit (20+ min) | 691 | $49 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 13 | $0 |
| HEMOGLOBIN | 74 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 31 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 98 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 51 | $0 |
| Screening test, pure tone, air only | 12 | $0 |
| Bilateral quantitative screening test of visual acuity | 15 | $0 |
| Return visit (30+ min) | 37 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $0 |
Drugs they prescribed that Part D paid
$267,227
Pharmacies billed $267,227 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,420 generic and 397 brand-name prescriptions · $267,227 in drug cost · 71 antibiotic prescriptions to 55 people · 18 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 62 | $67,019 | $1,081 |
| Jardiance | 45 | $31,688 | $704 |
| Eliquis | 31 | $29,602 | $955 |
| Rybelsus | 16 | $21,176 | $1,324 |
| Basaglar Kwikpen U-100 | 12 | $7,276 | $606 |
See all 60 drugs
| Ozempic | 62 | $67,019 | $1,081 |
| Jardiance | 45 | $31,688 | $704 |
| Eliquis | 31 | $29,602 | $955 |
| Rybelsus | 16 | $21,176 | $1,324 |
| Basaglar Kwikpen U-100 | 12 | $7,276 | $606 |
| Advair Hfa | 17 | $5,221 | $307 |
| Albuterol Sulfate Hfa | 65 | $2,310 | $36 |
| Atorvastatin | 211 | $2,205 | $10 |
| Lantus Solostar | 16 | $1,607 | $100 |
| Famotidine | 132 | $1,516 | $11 |
| Duloxetine | 48 | $1,152 | $24 |
| Hydroxyzine | 48 | $1,006 | $21 |
| Gabapentin | 79 | $989 | $13 |
| Ziprasidone | 12 | $918 | $76 |
| Levothyroxine | 144 | $862 | $6 |
| Metformin | 135 | $852 | $6 |
| Losartan | 112 | $847 | $8 |
| Oxybutynin Chloride | 22 | $664 | $30 |
| Telmisartan | 27 | $628 | $23 |
| Diclofenac | 35 | $537 | $15 |
| Montelukast | 58 | $530 | $9 |
| Chlorthalidone | 32 | $484 | $15 |
| Clopidogrel | 29 | $464 | $16 |
| Fluticasone Propionate | 32 | $456 | $14 |
| Metoprolol | 59 | $436 | $7 |
| Ezetimibe | 23 | $409 | $18 |
| Amlodipine Besylate | 137 | $401 | $3 |
| Lidocaine Hcl Viscous | 17 | $357 | $21 |
| Nifedipine Er | 12 | $347 | $29 |
| Rosuvastatin | 32 | $339 | $11 |
| Omeprazole | 27 | $309 | $11 |
| Olmesartan Medoxomil | 13 | $262 | $20 |
| Lisinopril | 70 | $249 | $4 |
| Pantoprazole | 26 | $230 | $9 |
| Propranolol | 36 | $210 | $6 |
| Amitriptyline | 15 | $208 | $14 |
| Simvastatin | 18 | $201 | $11 |
| Glipizide | 34 | $176 | $5 |
| Ibuprofen | 62 | $175 | $3 |
| Glimepiride | 15 | $172 | $11 |
| Nitrofurantoin Mono-Macro | 13 | $164 | $13 |
| Allopurinol | 18 | $159 | $9 |
| Tamsulosin | 14 | $147 | $11 |
| Escitalopram | 17 | $141 | $8 |
| Valsartan | 11 | $139 | $13 |
| Hydrochlorothiazide | 32 | $118 | $4 |
| Sertraline | 37 | $108 | $3 |
| Amoxicillin-Clavulanate Potass | 11 | $94 | $9 |
| Ketoconazole | 15 | $93 | $6 |
| Paroxetine | 24 | $93 | $4 |
| Trazodone | 17 | $87 | $5 |
| Naproxen | 24 | $48 | $2 |
| Azithromycin | 20 | $47 | $2 |
| Triamcinolone Acetonide | 21 | $44 | $2 |
| Furosemide | 17 | $38 | $2 |
| Meloxicam | 28 | $36 | $1 |
| Alendronate | 11 | $34 | $3 |
| Zolpidem | 12 | $20 | $2 |
| Lisinopril-Hydrochlorothiazide | 11 | $19 | $2 |
| Ramipril | 11 | $13 | $1 |
Year by year
| 2024 | 2,833 | 195 | None | 14% | $267,227 |
| 2023 | 1,972 | 132 | None | 13% | $218,321 |
| 2022 | 1,770 | 127 | None | 14% | $176,249 |
| 2021 | 1,121 | 86 | 0% (0) | None | $87,427 |
| 2020 | 900 | 76 | None | None | $68,634 |
| 2019 | 129 | 22 | None | 26% | $9,990 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 50 drugs
| Rybelsus | 19 | $30,689 | $1,615 |
| Ozempic | 25 | $25,112 | $1,004 |
| Jardiance | 31 | $24,849 | $802 |
| Trulicity | 14 | $18,171 | $1,298 |
| Eliquis | 21 | $16,090 | $766 |
| Januvia | 12 | $15,157 | $1,263 |
| Basaglar Kwikpen U-100 | 18 | $10,896 | $605 |
| Advair Hfa | 15 | $6,593 | $440 |
| Flovent Hfa | 12 | $3,928 | $327 |
| Atorvastatin | 141 | $2,776 | $20 |
| Famotidine | 107 | $2,233 | $21 |
| Albuterol Sulfate Hfa | 50 | $1,982 | $40 |
| Metformin | 93 | $1,534 | $16 |
| Gabapentin | 57 | $1,478 | $26 |
| Losartan | 75 | $1,266 | $17 |
| Hydroxyzine | 29 | $1,099 | $38 |
| Levothyroxine | 73 | $971 | $13 |
| Amlodipine Besylate | 81 | $969 | $12 |
| Fluticasone Propionate | 22 | $910 | $41 |
| Duloxetine | 28 | $882 | $31 |
| Diclofenac | 32 | $838 | $26 |
| Telmisartan | 22 | $827 | $38 |
| Lisinopril | 72 | $807 | $11 |
| Metoprolol | 30 | $765 | $26 |
| Bupropion | 23 | $686 | $30 |
| Montelukast | 61 | $678 | $11 |
| Nifedipine Er | 17 | $637 | $37 |
| Valsartan | 23 | $581 | $25 |
| Chlorthalidone | 19 | $499 | $26 |
| Glipizide | 29 | $411 | $14 |
| Fenofibrate | 13 | $403 | $31 |
| Ibuprofen | 64 | $401 | $6 |
| Rosuvastatin | 13 | $397 | $31 |
| Omeprazole | 27 | $361 | $13 |
| Clopidogrel | 12 | $344 | $29 |
| Simvastatin | 24 | $338 | $14 |
| Oxybutynin Chloride | 20 | $285 | $14 |
| Tamsulosin | 21 | $279 | $13 |
| Sertraline | 20 | $261 | $13 |
| Pantoprazole | 16 | $260 | $16 |
| Naproxen | 12 | $252 | $21 |
| Hydrochlorothiazide | 30 | $208 | $7 |
| Hydrocortisone | 16 | $195 | $12 |
| Allopurinol | 22 | $175 | $8 |
| Finasteride | 11 | $109 | $10 |
| Propranolol | 12 | $109 | $9 |
| Metoprolol | 14 | $87 | $6 |
| Azithromycin | 19 | $86 | $5 |
| Sumatriptan | 12 | $40 | $3 |
| Zolpidem | 12 | $37 | $3 |
2022: 40 drugs
| Jardiance | 43 | $31,523 | $733 |
| Rybelsus | 28 | $28,587 | $1,021 |
| Januvia | 24 | $15,739 | $656 |
| Basaglar Kwikpen U-100 | 22 | $15,316 | $696 |
| Trulicity | 14 | $13,195 | $943 |
| Eliquis | 20 | $11,158 | $558 |
| Gabapentin | 66 | $2,709 | $41 |
| Atorvastatin | 166 | $1,919 | $12 |
| Albuterol Sulfate Hfa | 36 | $1,529 | $42 |
| Famotidine | 63 | $811 | $13 |
| Levothyroxine | 58 | $734 | $13 |
| Nifedipine Er | 21 | $684 | $33 |
| Losartan | 77 | $643 | $8 |
| Metformin | 113 | $623 | $6 |
| Chlorthalidone | 22 | $599 | $27 |
| Hydroxyzine | 40 | $572 | $14 |
| Metoprolol | 27 | $547 | $20 |
| Lisinopril | 63 | $544 | $9 |
| Amlodipine Besylate | 73 | $466 | $6 |
| Propranolol | 18 | $428 | $24 |
| Fenofibrate | 15 | $422 | $28 |
| Baclofen | 19 | $415 | $22 |
| Glimepiride | 11 | $384 | $35 |
| Montelukast | 35 | $363 | $10 |
| Diclofenac | 20 | $358 | $18 |
| Ibuprofen | 48 | $241 | $5 |
| Glipizide | 32 | $179 | $6 |
| Omeprazole | 30 | $176 | $6 |
| Simvastatin | 13 | $159 | $12 |
| Hydrochlorothiazide | 21 | $153 | $7 |
| Sertraline | 18 | $152 | $8 |
| Oxybutynin Chloride | 18 | $150 | $8 |
| Paroxetine | 14 | $143 | $10 |
| Carvedilol | 13 | $122 | $9 |
| Azithromycin | 14 | $107 | $8 |
| Buspirone | 12 | $100 | $8 |
| Atenolol | 11 | $83 | $8 |
| Tamsulosin | 12 | $60 | $5 |
| Zolpidem | 12 | $37 | $3 |
| Citalopram Hbr | 11 | $29 | $3 |
2021: 31 drugs
| Trulicity | 19 | $16,697 | $879 |
| Eliquis | 19 | $9,305 | $490 |
| Basaglar Kwikpen U-100 | 16 | $8,982 | $561 |
| Gabapentin | 52 | $1,698 | $33 |
| Albuterol Sulfate Hfa | 32 | $1,220 | $38 |
| Atorvastatin | 85 | $1,054 | $12 |
| Baclofen | 25 | $612 | $24 |
| Levothyroxine | 41 | $516 | $13 |
| Famotidine | 38 | $307 | $8 |
| Metformin | 61 | $231 | $4 |
| Amlodipine Besylate | 31 | $221 | $7 |
| Hydroxyzine | 19 | $212 | $11 |
| Verapamil Er | 12 | $192 | $16 |
| Simvastatin | 17 | $185 | $11 |
| Memantine | 12 | $181 | $15 |
| Ibuprofen | 29 | $179 | $6 |
| Montelukast | 13 | $164 | $13 |
| Omeprazole | 22 | $159 | $7 |
| Lisinopril | 53 | $148 | $3 |
| Citalopram Hbr | 15 | $136 | $9 |
| Pantoprazole | 13 | $131 | $10 |
| Oxybutynin Chloride | 16 | $129 | $8 |
| Losartan | 25 | $124 | $5 |
| Euthyrox | 12 | $114 | $10 |
| Telmisartan | 12 | $95 | $8 |
| Atenolol | 17 | $92 | $5 |
| Glipizide | 26 | $83 | $3 |
| Sertraline | 11 | $55 | $5 |
| Naproxen | 12 | $55 | $5 |
| Zolpidem | 14 | $45 | $3 |
| Hydrochlorothiazide | 16 | $43 | $3 |
2020: 23 drugs
| Trulicity | 27 | $21,829 | $808 |
| Eliquis | 12 | $5,545 | $462 |
| Levothyroxine | 49 | $677 | $14 |
| Atorvastatin | 60 | $607 | $10 |
| Albuterol Sulfate Hfa | 14 | $568 | $41 |
| Gabapentin | 42 | $465 | $11 |
| Baclofen | 13 | $363 | $28 |
| Metoprolol | 17 | $254 | $15 |
| Lisinopril | 62 | $220 | $4 |
| Omeprazole | 23 | $214 | $9 |
| Hydroxyzine | 21 | $208 | $10 |
| Metformin | 51 | $206 | $4 |
| Buspirone | 12 | $202 | $17 |
| Losartan | 25 | $197 | $8 |
| Famotidine | 14 | $152 | $11 |
| Ibuprofen | 22 | $140 | $6 |
| Simvastatin | 16 | $97 | $6 |
| Amlodipine Besylate | 25 | $94 | $4 |
| Atenolol | 20 | $70 | $3 |
| Lovastatin | 14 | $60 | $4 |
| Pantoprazole | 11 | $55 | $5 |
| Glipizide | 15 | $53 | $4 |
| Triamterene-Hydrochlorothiazid | 11 | $44 | $4 |
2019: 3 drugs
| Levothyroxine | 12 | $107 | $9 |
| Ibuprofen | 11 | $95 | $9 |
| Lisinopril | 12 | $47 | $4 |
Money from drug and device companies
$30,276 in 2025
| 2025 | 14 | 39 | $29,700 | $30,276 |
| 2024 | 9 | 26 | $32,200 | $32,465 |
| 2023 | 9 | 19 | $20,800 | $21,019 |
| 2022 | 4 | 10 | $11,300 | $11,846 |
| 2021 | 5 | 10 | None | $159 |
| 2020 | 2 | 2 | None | $30 |
| 2019 | 1 | 6 | None | $137 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | None | $29,700 | 11 payments
|
| Abbvie | Qulipta | $145 | 6 payments
|
| Novo Nordisk | Wegovy | $114 | 5 payments
|
| Shield Therapeutics | Accrufer | $72 | 3 payments
|
| Lilly USA | Mounjaro | $50 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $35 | 2 payments
|
See all 39 published payments
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-11-12 | None | $2,700 |
| Verrica Pharmaceuticals | Meals · 2025-10-29 | Ycanth | $17 |
| Novo Nordisk | Meals · 2025-10-16 | Wegovy | $24 |
| Shield Therapeutics | Meals · 2025-10-16 | Accrufer | $16 |
| Pfizer | Meals · 2025-10-09 | Paxlovid | $23 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-10-08 | None | $2,700 |
| Lilly USA | Meals · 2025-10-02 | Mounjaro | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-01 | Kerendia | $17 |
| Abbvie | Meals · 2025-09-30 | Qulipta | $27 |
| Abbvie | Meals · 2025-09-23 | Qulipta | $31 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-09-10 | None | $2,700 |
| Seqirus USA | Meals · 2025-08-29 | Flucelvax | $13 |
| Novo Nordisk | Meals · 2025-08-14 | Wegovy | $17 |
| Lilly USA | Meals · 2025-08-11 | Mounjaro | $15 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-08-08 | None | $2,700 |
| Novo Nordisk | Meals · 2025-07-28 | Ozempic | $27 |
| Amgen | Meals · 2025-07-24 | Otezla | $14 |
| Lilly USA | Meals · 2025-07-22 | Mounjaro | $18 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-07-11 | None | $2,700 |
| Cranial Technologies | Meals · 2025-07-10 | Doc Band | $13 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-06-11 | None | $2,700 |
| Novo Nordisk | Meals · 2025-06-02 | Ozempic | $19 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-05-09 | None | $2,700 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-01 | Kerendia | $18 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-04-11 | None | $2,700 |
| Abbvie | Meals · 2025-04-10 | Ubrelvy | $28 |
| Novo Nordisk | Meals · 2025-04-03 | Wegovy | $26 |
| Cranial Technologies | Meals · 2025-03-20 | Doc Band | $16 |
| Abbvie | Meals · 2025-03-19 | Qulipta | $29 |
| Shield Therapeutics | Meals · 2025-03-14 | Accrufer | $26 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-03-12 | None | $2,700 |
| Abbvie | Meals · 2025-02-27 | Ubrelvy | $5 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-02-12 | None | $2,700 |
| Astellas Pharma US | Meals · 2025-02-06 | Veozah | $21 |
| Abbvie | Meals · 2025-02-05 | Ubrelvy | $26 |
| Shield Therapeutics | Meals · 2025-01-27 | Accrufer | $31 |
| Dynavax Technologies | Meals · 2025-01-23 | Heplisav-B | $29 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-01-17 | None | $2,700 |
| Ultragenyx Pharmaceutical | Meals · 2025-01-16 | Crysvita | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $32,465
| Takeda Pharmaceuticals U.S.A. | None | $32,200 | 12 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $74 | 4 payments
|
| Novo Nordisk | Wegovy | $42 | 2 payments
|
| Ultragenyx Pharmaceutical | Crysvita | $41 | 2 payments
|
| Pfizer | Paxlovid | $38 | 2 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $20 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $19 | 1 payment
|
| Lilly USA | Mounjaro | $16 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $15 | 1 payment
|
2023: $21,019
| Takeda Pharmaceuticals U.S.A. | None | $20,800 | 8 payments
|
| Lilly USA | Mounjaro | $58 | 3 payments
|
| Novo Nordisk | Ozempic | $37 | 2 payments
|
| GlaxoSmithKline | Shingrix | $24 | 1 payment
|
| Sanofi Pasteur | Beyfortus | $22 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $22 | 1 payment
|
| Pfizer | Nurtec Odt | $20 | 1 payment
|
| Cranial Technologies | Doc Band | $20 | 1 payment
|
| Ultragenyx Pharmaceutical | None | $15 | 1 payment
|
2022: $11,846
| Takeda Pharmaceuticals U.S.A. | None | $11,775 | 6 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $38 | 2 payments
|
| Novo Nordisk | Rybelsus | $18 | 1 payment
|
| Cranial Technologies | Doc Band | $15 | 1 payment
|
2021: $159
| Lilly USA | Trulicity | $51 | 3 payments
|
| Novo Nordisk | Rybelsus | $45 | 3 payments
|
| Cranial Technologies | Doc Band | $28 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $22 | 1 payment
|
| Phadia US | Immunocap | $13 | 1 payment
|
2020: $30
| Sanofi Pasteur | Flublok Quadrivalent Northern Hemisphere | $15 | 1 payment
|
| Lilly USA | Basaglar | $14 | 1 payment
|
2019: $137
| Lilly USA | Trulicity | $137 | 6 payments
|
Professional record
- NPI
- 1801349683
- Licence
- CA A157666California A157666: Current · expires 2028-08-31
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 21890 W Colorado Avenue, San Joaquin, CA, 93660
- NPI first listed
- 2016-07-28
- NPI last updated
- 2019-08-26
This is when the NPI record was last certified, not a medical board exam.